Pharmafile Logo
Pharmafocus logo
Advanced Search

Clinigen

Showing 8 posts of 8 posts found.

shutterstock_138095450

Clinigen becomes sole license holder of cancer drug Proleukin in $210m deal

February 14, 2019
Sales and Marketing Clinigen, Novartis, Proleukin, pharma

Novartis has arranged to sell the remainder of its rights to its skin and lung cancer drug Proleukin (aldesleukin, recombinant …

News
image_credit_-_rafael_matsunaga

Clinigen shares soar after $210m Novartis cancer drug deal

February 13, 2019
Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology

British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …

News
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …

News
Clinigen logo

Clinigen launches UK managed access program for Takeda’s ixazomib

November 30, 2015
Sales and Marketing Clinigen, Takeda, ixazomib, managed access, multiple myeloma, oncology

Clinigen and Takeda have struck a deal to allow patients in the UK to access the multiple myeloma drug ixazomib …

News
Chief executive Peter George image

Clinigen buys Idis for £225 million

April 24, 2015
Sales and Marketing CBPE Capital, Clinigen, IDIS, unlicensed

UK speciality pharma group Clinigen is paying £225 million to acquire the Surrey-based unlicensed supplier of medicines firm Idis. Unlicensed …

News
peter_george_ceo_clinigen_group

Clinigen chief executive joins Ergomed board

May 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, ergomed, george

UK drug development
 services firm Ergomed has appointed Peter George to its
board as a non-executive director.

  George has over 20 …

Appointment
screen_shot_2013-01-11_at_10

Dominic Atkins joins Clinigen GAP in senior commercial role

January 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins

Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …

Appointment

Chief operating officer appointed to Clinigen’s services division

January 19, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …

Appointment

Latest content

Shionogi and Maze Therapeutics announce worldwide exclusive licensing agreement for novel Pompe disease candidate

May 10, 2024

Sanofi and Novavex sign exclusive $1.2bn licensing agreement to co-commercialise COVID-19 vaccine and develop flu-COVID-19 vaccines

May 10, 2024

AstraZeneca withdraws COVID-19 vaccine Vaxzevria

May 9, 2024

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024

Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet

May 8, 2024